Northern Trust Corp Entera Bio Ltd. Transaction History
Northern Trust Corp
- $690 Billion
- Q4 2024
A detailed history of Northern Trust Corp transactions in Entera Bio Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 212,483 shares of ENTX stock, worth $492,960. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,483Holding current value
$492,960% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENTX
# of Institutions
18Shares Held
7.52MCall Options Held
24.5KPut Options Held
0-
Knoll Capital Management, LLC Miami, FL5.88MShares$13.6 Million7.89% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY632KShares$1.47 Million0.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT414KShares$959,8580.13% of portfolio
-
Perigon Wealth Management, LLC San Francisco, CA146KShares$338,3550.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny61.8KShares$143,3760.0% of portfolio
About Entera Bio Ltd.
- Ticker ENTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,809,900
- Market Cap $66.8M
- Description
- Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...